Johnson and Johnson has announced the acquisition of the medical technology firm Orthotaxy for an undisclosed fee.
Orthotaxy is a developer of software-enabled surgery technologies, including a differentiated robotic-assisted surgery solution that is currently in early-stage development for total and partial knee replacement.
“Johnson and Johnson has agreed to acquire Orthotaxy, a new developer of software-enabled surgery technologies.“
Johnson and Johnson is hoping to broaden the application of this system for a range of orthopaedic surgery procedures, and to provide benefits in terms of cost-effectiveness, time-efficiency and user-friendliness.
This acquisition underscores the company's commitment in building an innovative and comprehensive digital surgery platform, as Johnson and Johnson is looking to focus on digital technology solutions spanning the full continuum of care.
Ciro Romer, chairman of Johnson and Johnson's orthopaedics business DePuy Synthes, said: "The team at Orthotaxy has significant expertise and passion in developing this platform, and we aspire to bring to market a differentiated technology that helps improve clinical outcomes and increases patient satisfaction."
With over 20 years of experience within the consumer market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current consumer roles we have available, you can search for the latest job roles, register your details, or contact the team today.See all the latest jobs in Medical Devices